MHRA grants conditional marketing authorization for AbbVie's Tepkinly to treat aggressive blood cancer - Tepkinly® (epcoritamab)

https://www.news-medical.net/news/20231028/MHRA-grants-conditional-marketing-authorization-for-AbbVies-Tepkinly-to-treat-aggressive-blood-cancer.aspx